Editor: What To Know
- Her leadership has resulted in the successful acquisition of companies and technologies that expand the Orthofix portfolio of solutions, including the M6-C™ artificial cervical disc that mimics the natural motion of a native disc, the Fitbone internal limb lengthening system that corrects limb differentials, significant expansion of our biologics portfolio, and key investments in differentiated technologies such as nView medical and Neo Medical.
- “With more than 25 years in the medical device space, a track record of success at Orthofix Medical, and a demonstrated passion for our Orthopedics business, Kim will bring strong leadership and meaningful perspective to this business,” said Orthofix President and CEO Jon Serbousek.
- Kimberley Elting said, “The Orthopedics business was the foundation for Orthofix over forty years ago when this company was started in Verona, Italy, and it has a long history of providing meaningful products and life-changing patient solutions to orthopedic surgeons world-wide.
Orthofix Medical Inc. today announced a leadership transition for its Orthopedics Business Unit.
Kimberley Elting, currently Chief Legal and Development Officer for Orthofix, will become the President of the Global Orthopedics business effective today. In this role, Kimberley Elting succeeds Paul Gonsalves, who is leaving the company to pursue other opportunities.
“With more than 25 years in the medical device space, a track record of success at Orthofix Medical, and a demonstrated passion for our Orthopedics business, Kim will bring strong leadership and meaningful perspective to this business,” said Orthofix President and CEO Jon Serbousek. “We have made significant investments to build the Orthopedics Business unit and we feel confident that she is the right person to lead this team to continue to drive growth in this sector of our business.”
Elting has significant experience in the medical device product life cycle, supporting research and development and commercialization, and leading business development initiatives that strengthened organic and inorganic company growth. Her leadership has resulted in the successful acquisition of companies and technologies that expand the Orthofix portfolio of solutions, including the M6-C™ artificial cervical disc that mimics the natural motion of a native disc, the Fitbone internal limb lengthening system that corrects limb differentials, significant expansion of our biologics portfolio, and key investments in differentiated technologies such as nView medical and Neo Medical. During the course of the last five years at Orthofix, she has led many functions at Orthofix including Regulatory and Quality, Corporate Communications, and Business Development, in addition to the Legal group. In the coming months she will transition her legal, business development and corporate communications responsibilities to new leaders.
Kimberley Elting said, “The Orthopedics business was the foundation for Orthofix over forty years ago when this company was started in Verona, Italy, and it has a long history of providing meaningful products and life-changing patient solutions to orthopedic surgeons world-wide. “I look forward to working with this talented team as we continue to innovate and bring to market differentiated products and solutions for pediatric and adult deformity correction and limb reconstruction, helping deliver on our commitment to improve patient mobility.”
Elting joined the Orthofix Medical Leadership team as Chief Legal Officer in September 2016, was named Chief Legal and Administrative Officer in 2017, and Chief Legal and Development Officer in 2020. A seasoned executive, she has a strong background in the medical device industry. Before coming to Orthofix, Elting served as General Counsel and Vice President Corporate Affairs at TriVascular Technologies, Inc.
In this role, she led the legal, compliance, human resources (HR) and government affairs functions for the company. Prior to this, Elting served in various roles of increasing responsibility with St. Jude Medical including General Counsel and Vice President of HR and Health Policy for the Neuromodulation Division. Elting previously was a partner at the Jones Day law firm. A graduate of Ithaca College, Elting earned her Law Degree from the University of Denver and an LL.M. in Health Law from Loyola University Chicago.
